Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adhera Therapeutics
Adhera Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Prestalia
Perindopril arginine
,
Amlodipine besylate
2015-01-21
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
autistic disorder
,
choroidal neovascularization
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
macular edema
,
macular degeneration
,
edema
,
lupus nephritis
,
nephritis
,
retinal vein occlusion
,
wet macular degeneration
,
diabetic nephropathies
,
renal cell carcinoma
,
bcr-abl positive chronic myelogenous leukemia
,
melanoma
,
myasthenia gravis
,
retinal neovascularization
,
anemia
,
chronic renal insufficiency
,
kidney diseases
,
kidney transplantation
,
chronic kidney failure
Aglatimagene besadenovec
carcinoma
,
lymphoma
,
triple negative breast neoplasms
,
lung neoplasms
,
pharmacokinetics
,
healthy volunteers/patients
,
pharmacological phenomena
,
breast neoplasms
,
adenocarcinoma
,
neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
uterine cervical neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
biliary tract neoplasms
,
bone neoplasms
,
bone diseases
,
hereditary sensory and autonomic neuropathies
,
hereditary breast and ovarian cancer syndrome
,
glioma
,
fallopian tube neoplasms
,
astrocytoma
,
head and neck neoplasms
,
dna repair-deficiency disorders
,
sarcoma
,
x-linked bulbo-spinal atrophy
,
neoplasm metastasis
,
recurrence
,
gynecomastia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
heart failure
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
osteoporosis
,
obesity
,
hepatocellular carcinoma
,
liver neoplasms
Intermedine
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Isoxaflutole
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use